[1]Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013;131(3):548-558.[2]曹克将,孔祥清.规范我国先天性心脏病介入治疗的必要性和重要意义[J].中华儿科杂志, 2004, 42(11):806-807.[3]Steeds RP, Oakley D. Predicting late sudden death from ventricular arrhythmia in adults following surgical repair of tetralogy of Fallot. QJM. 2004;97(1):7-13.[4]O'Brien MF, Harrocks S, Clarke A, et al. How to do safe sternal reentry and the risk factors of redo cardiac surgery: a 21-year review with zero major cardiac injury. J Card Surg. 2002;17(1):4-13.[5]Dobell AR, Jain AK. Catastrophic hemorrhage during redo sternotomy. Ann Thorac Surg. 1984;37(4):273-278.[6]Hong JH, Choe JW, Kwon GY, et al. The effects of barrier materials on reduction of pericardial adhesion formation in rabbits: a comparative study of a hyaluronan-based solution and a temperature sensitive poloxamer solution/gel material. J Surg Res. 2011;166(2):206-213.[7]Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263-2270.[8]Stevens KR, Kreutziger KL, Dupras SK, et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A. 2009; 106(39):16568-16573.[9]Park SO, Han J, Minn KW, et al. Prevention of capsular contracture with Guardix-SG(®) after silicone implant insertion. Aesthetic Plast Surg. 2013;37(3):543-548.[10]Kang H, Chung YS, Kim SW, et al. Effect of Temperature-Sensitive Poloxamer Solution/Gel Material on Pericardial Adhesion Prevention: Supine Rabbit Model Study Mimicking Cardiac Surgery. PLoS One. 2015;10(11): e0143359.[11]Walther T, Rastan A, Dähnert I, et al. A novel adhesion barrier facilitates reoperations in complex congenital cardiac surgery. J Thorac Cardiovasc Surg. 2005;129(2):359-363.[12]Khalpey Z, Marsh KM, Ferng A, et al. First in man: amniotic patch reduces postoperative inflammation. Am J Med. 2015; 128(1):e5-6.[13]Heydrick S, Roberts E, Kim J, et al. Pediatric cardiovascular grafts: historical perspective and future directions. Curr Opin Biotechnol. 2016;40:119-124.[14] Ruzmetov M, Shah JJ, Geiss DM, et al. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg. 2012;143(3):543-549.[15]Ozawa H, Miyagawa S, Fukushima S, et al. Extracellar Matrix Preserving Decellulerized Heart Valve Maintain Valvular Function in vivo by Enhancing Functional Cell Recellularization. Circulation. 2014; 130:A16120.[16]Phelps EA, García AJ. Engineering more than a cell: vascularization strategies in tissue engineering. Curr Opin Biotechnol. 2010;21(5):704-709.[17]Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A. 2004;101(52):18129-18134.[18]Takawale A, Sakamuri SS, Kassiri Z. Extracellular matrix communication and turnover in cardiac physiology and pathology. Compr Physiol. 2015;5(2):687-719.[19]Park JS, Cha SJ, Kim BG, et al. An assessment of the effects of a hyaluronan-based solution on reduction of postsurgical adhesion formation in rats: a comparative study of hyaluronan-based solution and two film barriers. J Surg Res. 2011;168(1):49-55.[20]Sakai T, Li RK, Weisel RD, et al. The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg. 2001;121(5): 932-942.[21]Griffith CK, Miller C, Sainson RC, et al. Diffusion limits of an in vitro thick prevascularized tissue.Tissue Eng. 2005;11(1-2): 257-266.[22]Lv S, Dudek DM, Cao Y, et al. Designed biomaterials to mimic the mechanical properties of muscles. Nature. 2010;465 (7294): 69-73. [23]Stoppato M, Stevens HY, Carletti E, et al. Effects of silk fibroin fiber incorporation on mechanical properties, endothelial cell colonization and vascularization of PDLLA scaffolds. Biomaterials. 2013n;34(19):4573-4581.[24]Frescaline G, Bouderlique T, Mansoor L, et al. Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo. Tissue Eng Part A. 2013;19(13-14):1641-1653.[25]Syedain ZH, Bradee AR, Kren S, et al. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A. 2013;19(5-6):759-769.[26]Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res. 2014;114(2):354-367.[27]Weber B, Dijkman PE, Scherman J, et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials. 2013;34(30):7269-7280.[28]Gaustad KG, Boquest AC, Anderson BE, et al. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun. 2004; 314(2):420-427.[29]Chiavegato A, Bollini S, Pozzobon M, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol. 2007;42(4):746-759.[30]Syedain ZH, Meier LA, Bjork JW, et al. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials. 2011;32(3):714-722.[31]McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet. 2009;373(9673):1440-1446.[32]Boccardo S, Gaudiello E, Melly L, et al. Engineered mesenchymal cell-based patches as controlled VEGF delivery systems to induce extrinsic angiogenesis. Acta Biomater. 2016;42:127-135. |